Status:

COMPLETED

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

Lead Sponsor:

Jonsson Comprehensive Cancer Center

Collaborating Sponsors:

Faxitron bioptics, LLC

Conditions:

Positive Axillary Lymph Node

Stage 0 Breast Cancer AJCC v6 and v7

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

This pilot clinical trial will evaluate whether the SCOUT reflector can be used to tag abnormal lymph nodes in patients with breast cancer prior to chemotherapy for targeted removal at the time of sur...

Detailed Description

PRIMARY OBJECTIVES: I. Percentage of patients with successful retrieval of the reflector confirmed by specimen radiography. II. Percentage of patients with successful retrieval of the biopsied node,...

Eligibility Criteria

Inclusion

  • Able to give written informed consent to participate in the study
  • Patients with a breast cancer diagnosis of any subtype and a biopsy-proven positive axillary lymph node who will be treated first with chemotherapy
  • Enlarged lymph node and/or clip targetable with image guidance
  • Patients who are eligible for surgical resection of the primary breast cancer and targeted dissection of the axilla

Exclusion

  • More than 3 positive axillary nodes on imaging or matted nodes on clinical exam
  • Stage IV breast cancer
  • Pregnant or lactating females
  • Patients with inflammatory breast cancer
  • Patients with allergies to isosulfan blue or technetium, which would preclude sentinel node mapping
  • Patients who have had previous axillary surgery, including sentinel lymph node biopsy

Key Trial Info

Start Date :

April 7 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 6 2021

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT03411070

Start Date

April 7 2019

End Date

December 6 2021

Last Update

January 17 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, United States, 90095